Mwanzo1SXP • ETR
add
SCHOTT Pharma AG & Co KgaA
Bei iliyotangulia
€ 31.10
Bei za siku
€ 31.22 - € 32.40
Bei za mwaka
€ 25.64 - € 43.40
Thamani ya kampuni katika soko
4.78B EUR
Wastani wa hisa zilizouzwa
elfu 59.63
Uwiano wa bei na mapato
31.18
Mgao wa faida
0.48%
Ubadilishanaji wa msingi
ETR
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (EUR) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 253.59M | 14.56% |
Matumizi ya uendeshaji wa biashara | 34.65M | -5.38% |
Mapato halisi | 46.26M | 51.75% |
Kiwango cha faida halisi | 18.24 | 32.46% |
Mapato kwa kila hisa | 0.31 | — |
EBITDA | 68.93M | 22.98% |
Asilimia ya kodi ya mapato | 16.95% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (EUR) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 22.15M | 6.00% |
Jumla ya mali | 1.40B | 21.33% |
Jumla ya dhima | 629.73M | 25.46% |
Jumla ya hisa | 769.30M | — |
hisa zilizosalia | 148.88M | — |
Uwiano wa bei na thamani | 6.03 | — |
Faida inayotokana na mali | 9.50% | — |
Faida inayotokana mtaji | 12.72% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (EUR) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 46.26M | 51.75% |
Pesa kutokana na shughuli | 57.92M | 38.02% |
Pesa kutokana na uwekezaji | -24.22M | 25.80% |
Pesa kutokana na ufadhili | -30.05M | -229.21% |
Mabadiliko halisi ya pesa taslimu | 3.14M | 16,615.79% |
Mtiririko huru wa pesa | 39.58M | — |
Kuhusu
Schott Pharma is a provider of drug containment solutions and delivery systems for injectable drugs. Originally a subsidiary of the glass manufacturer Otto Schott, the company went private and subsequently entered the Frankfurst Stock Exchange in 2023. Headquartered in Mainz, Germany, the company operates in 14 countries. Wikipedia
Ilianzishwa
1 Ago 2022
Tovuti
Wafanyakazi
4,681
